Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
7.13
-0.32 (-4.32%)
At close: May 12, 2025, 4:00 PM
7.00
-0.13 (-1.80%)
Pre-market: May 13, 2025, 8:45 AM EDT
Liminatus Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -4.09 | -4.98 | -2.93 |
| Asset Writedown & Restructuring Costs | - | - | 0.9 |
| Change in Accounts Payable | 0.53 | 0.43 | 0.09 |
| Change in Other Net Operating Assets | 1.93 | 1.21 | 1.07 |
| Operating Cash Flow | -1.63 | -3.35 | -0.87 |
| Investing Cash Flow | -2.77 | -0.82 | - |
| Short-Term Debt Issued | - | 3.41 | 9.44 |
| Total Debt Issued | 4.62 | 3.41 | 9.44 |
| Short-Term Debt Repaid | - | -3.86 | -7.03 |
| Total Debt Repaid | -0.2 | -3.86 | -7.03 |
| Net Debt Issued (Repaid) | 4.42 | -0.45 | 2.42 |
| Issuance of Common Stock | - | - | 4.2 |
| Repurchase of Common Stock | - | - | -0.7 |
| Financing Cash Flow | 4.42 | -0.45 | 5.92 |
| Net Cash Flow | 0.03 | -4.61 | 5.05 |
| Cash Interest Paid | - | - | 0.5 |
| Levered Free Cash Flow | - | -2.3 | - |
| Unlevered Free Cash Flow | - | -2.19 | - |
| Change in Net Working Capital | - | -0.82 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.